People who are prescribed Ozempic to treat type 2 diabetes, but whose insurance does not cover it, or who don’t have insurance, will be able to buy the medication at a lower cost. Novo Nordisk announced on Monday that it will offer Ozempic for $499 a month through the GoodRx platform.

Novo Nordisk reduces Ozempic's price to $499/month for self-paying patients, enhancing access to essential diabetes treatment and ensuring patient safety.